Press release
Blood Glucose Monitoring Devices Market Outlook 2025-2034: Driving Innovation in Diabetes Care
Blood Glucose Monitoring Devices
These devices have evolved from simple finger-prick glucometers to continuous glucose monitoring (CGM) systems, flash glucose monitors, and smartphone-integrated solutions. The integration of artificial intelligence (AI), data analytics, and wearable technologies is reshaping how patients and healthcare providers manage diabetes.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/73466
Market Overview
The global blood glucose monitoring devices market was valued at USD 14.2 billion in 2024 and is projected to reach USD 29.8 billion by 2034, growing at a CAGR of 7.6% (2024-2034).
Key Highlights:
• Rising prevalence of diabetes worldwide, especially in emerging markets.
• Strong adoption of CGMs and flash glucose monitoring devices.
• Integration with mobile apps, cloud platforms, and AI-driven tools.
• Expanding role of devices in preventive healthcare and telemedicine.
Market Segmentation
• By Product Type
o Self-Monitoring Blood Glucose (SMBG) Devices
Glucometers
Test Strips
Lancets
o Continuous Glucose Monitoring (CGM) Systems
Sensors
Transmitters
Receivers
• By Technology
o Invasive Monitoring Devices
o Non-Invasive/Minimally Invasive Devices
• By Application
o Type 1 Diabetes
o Type 2 Diabetes
o Gestational Diabetes
• By End User
o Hospitals & Clinics
o Homecare Settings
o Diagnostic Centers
o Others
Summary:
Self-monitoring devices still dominate due to affordability and widespread use, but continuous glucose monitoring systems are the fastest-growing segment, fueled by demand for real-time and less invasive monitoring. Type 2 diabetes accounts for the largest application share globally.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73466/blood-glucose-monitoring-devices-market
Regional Analysis
• North America: Largest market, driven by high diabetes prevalence, insurance coverage, and adoption of advanced CGM devices.
• Europe: Strong growth due to supportive healthcare systems and rising use of CGM in both hospitals and homecare.
• Asia-Pacific: Fastest-growing region, with high diabetes incidence in China and India, growing healthcare investments, and rising patient awareness.
• Middle East & Africa: Adoption rising, supported by public health initiatives and growing urban healthcare infrastructure.
• Latin America: Brazil and Mexico dominate regional growth, with expanding use of SMBG and gradual adoption of CGM.
Summary:
North America remains the largest market, while Asia-Pacific will experience the fastest growth due to its massive diabetic population and improving healthcare infrastructure.
Market Dynamics
Key Growth Drivers
• Rising prevalence of Type 1 and Type 2 diabetes.
• Increased demand for continuous and non-invasive monitoring.
• Integration with AI, IoT, and telemedicine platforms.
• Growing patient awareness and focus on self-management of chronic diseases.
Key Challenges
• High cost of advanced CGM systems.
• Limited accessibility in low-income countries.
• Regulatory complexities in device approvals.
• Concerns about data accuracy in some non-invasive solutions.
Latest Trends
• Growth of smartphone-integrated glucose monitors.
• Expansion of AI-driven predictive analytics for glucose management.
• Rising demand for needle-free and non-invasive monitoring.
• Emergence of subscription-based models for sensors and strips.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/check-discount/73466
Competitive Landscape
Major Players
• Abbott Laboratories (Freestyle Libre)
• Dexcom, Inc.
• Medtronic plc
• F. Hoffmann-La Roche Ltd.
• Ascensia Diabetes Care Holdings AG
• Becton, Dickinson and Company (BD)
• Senseonics Holdings, Inc.
• AgaMatrix, Inc.
• Lifescan, Inc.
• Ypsomed Holding AG
Summary:
Abbott and Dexcom dominate the CGM segment with leading products like Freestyle Libre and Dexcom G7. Roche, Ascensia, and Lifescan remain strong in the SMBG segment. Senseonics is pioneering long-term implantable CGM devices, while startups are driving innovation in non-invasive monitoring.
Conclusion
The blood glucose monitoring devices market is projected to reach USD 29.8 billion by 2034, growing at a CAGR of 7.6%.
• SMBG devices remain dominant, but CGM systems will fuel future growth.
• Type 2 diabetes represents the largest market share, with CGM adoption expanding across Type 1 and gestational diabetes.
• Asia-Pacific will be the fastest-growing region, while North America remains the innovation hub.
• Future growth will be driven by non-invasive technologies, AI integration, and patient-centric digital ecosystems.
This report is also available in the following languages : Japanese (血糖値モニタリングデバイス市場), Korean (혈당 측정 장치 시장), Chinese (血糖监测设备市场), French (Marché des dispositifs de surveillance de la glycémie), German (Markt für Blutzuckermessgeräte), and Italian (Mercato dei dispositivi di monitoraggio della glicemia), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73466
Our More Reports:
Aseptic Filling Machine Market
https://exactitudeconsultancy.com/reports/73535/aseptic-filling-machine-market
Non-Viral Transfection Reagents Market
https://exactitudeconsultancy.com/reports/73537/non-viral-transfection-reagents-market
Cell Sorting Market
https://exactitudeconsultancy.com/reports/73539/cell-sorting-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Blood Glucose Monitoring Devices Market Outlook 2025-2034: Driving Innovation in Diabetes Care here
News-ID: 4183186 • Views: …
More Releases from Exactitude Consultancy
Non-Invasive Diagnostics Market Outlook 2025-2034, Redefining Healthcare with Sa …
The global healthcare industry is shifting toward patient-centric and minimally invasive solutions, and diagnostics are no exception. Non-invasive diagnostics are transforming the way diseases are detected, monitored, and managed by eliminating or reducing the need for tissue biopsies, surgical procedures, or painful interventions.
From medical imaging (MRI, CT, ultrasound) to liquid biopsies, molecular diagnostics, and wearable sensors, non-invasive technologies are delivering faster, safer, and more accurate insights. Rising prevalence of chronic…
Human Factors and Usability Engineering Services Market Outlook 2025-2034, Optim …
In the medical device and healthcare technology industries, human factors and usability engineering (HFUE) services have become essential for ensuring that devices are safe, intuitive, and compliant with stringent regulatory requirements. These services help identify and mitigate risks associated with user interaction, reducing the likelihood of errors and enhancing patient outcomes.
HFUE plays a pivotal role in designing products ranging from drug delivery devices and diagnostic systems to surgical robotics and…
Targeted Drug Delivery Device Market Outlook 2025-2034, Advancing Precision in T …
The pharmaceutical and medical device industries are undergoing a profound transformation, with targeted drug delivery devices at the forefront. Unlike conventional drug delivery methods, which disperse medication throughout the body, targeted delivery focuses on directing therapeutic agents precisely to the site of action. This approach enhances drug efficacy, minimizes side effects, and improves patient outcomes.
These devices - including nanoparticle carriers, implantable pumps, micro-needles, and catheter-based systems - are playing a…
Companion Diagnostics (CDx) Development Market Outlook 2025-2034, Enabling Preci …
As the global healthcare system pivots toward personalized medicine, companion diagnostics (CDx) have emerged as a critical enabler. CDx are in-vitro diagnostic tests designed to identify whether a patient will benefit from a specific drug therapy, ensuring that treatments are safer, more effective, and tailored to individual needs.
These diagnostics are most commonly associated with oncology, where they help match patients to targeted therapies. However, their role is rapidly expanding into…
More Releases for CGM
Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days
Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions.
Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for…
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,…
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention.
In 2017, National Diabetes Services Scheme (NDSS) initiated by…
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)…
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes.
Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12
CMA CGM…
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market.
The global CGM market is undergoing a…
